Product Details
TREVICTA 263 mg prolonged release suspension for injection#
Paliperidone palmitate263mg
Suspension for injection
ROA
Intramuscular
Applicant Name
J & J Company West Africa Limited
NRN
A4-100553
Status
Active
Composition
ATC Code
N05AX13
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 1
Product Description
48 NF-PP-268959 TREVICTA 263 mg prolonged release suspension for injection Paliperidone palmitate Each TREVICTA 263 mg pre filled syringe contains 410 mg paliperidone palmitate The other ingredients are: Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100553 Drugs Imported Products 1*1 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium
Manufacturer Name
Janssen Pharmaceutica NV
Manufacturer Country
BELGIUM
Approval Date
2023-10-31
Expiry Date
2028-10-30